Shira Dvorachek - Seach Medical Director of Human Resources
| SEMG Stock | ILA 314.30 3.50 1.13% |
Insider
Shira Dvorachek is Director of Human Resources of Seach Medical Group since 2019.
| Age | 43 |
| Tenure | 5 years |
| Phone | 972 9 770 0009 |
| Web | https://www.seach.co.il |
Seach Medical Management Efficiency
The company has return on total asset (ROA) of 0.0416 % which means that it generated a profit of $0.0416 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0488 %, meaning that it generated $0.0488 on every $100 dollars invested by stockholders. Seach Medical's management efficiency ratios could be used to measure how well Seach Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Ziv Leitman | Suny Cellular Communication | 64 | |
| Eliahu BenNun | Amir Marketing and | 78 | |
| Ariel Shapir | Suny Cellular Communication | 54 | |
| Ilan Simon | Veridis Environment | 54 | |
| Rafael Arad | Petrochemical | 58 | |
| Ern Levy | Suny Cellular Communication | 48 | |
| Yehuda Reznik | Hiron Trade Investments Industr | 70 | |
| Dorit Zion | Hiron Trade Investments Industr | N/A | |
| Guy Kaveret | Amir Marketing and | 57 | |
| Gadi Tilvor | Suny Cellular Communication | 67 | |
| Ilan Biton | B Yair Building | 51 | |
| Giora Bitan | Suny Cellular Communication | 68 | |
| Roi Padida | Suny Cellular Communication | 37 | |
| Itzhak Bentzioni | Suny Cellular Communication | 60 | |
| Roni Eizenshtein | Petrochemical | 58 | |
| Yacov Gelbard | Suny Cellular Communication | 75 | |
| Orly Kamm | Petrochemical | N/A | |
| Yonatan LeAri | Hiron Trade Investments Industr | 47 | |
| Yosef Yitzchak | Hiron Trade Investments Industr | 70 | |
| Yossi Halfon | Suny Cellular Communication | 57 | |
| Bella CPA | B Yair Building | 46 | |
Management Performance
| Return On Equity | 0.0488 | |||
| Return On Asset | 0.0416 |
Seach Medical Group Leadership Team
Elected by the shareholders, the Seach Medical's board of directors comprises two types of representatives: Seach Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Seach. The board's role is to monitor Seach Medical's management team and ensure that shareholders' interests are well served. Seach Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Seach Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dalit Weichselbaum, External Director | ||
| Yehezkel Cohen, External Director | ||
| Yossi Levi, Independent Director | ||
| Nir Zichlinskey, Chairman of the Board | ||
| Margalit Sarid, Manager of Growing Facility | ||
| Samy Backlash, Director | ||
| Daniel Spira, Internal Auditor | ||
| Hagai Zachor, Business Development Manager | ||
| Arnon Salomon, Director | ||
| Iris Nesher, Chief Officer | ||
| Amichay Rab, Vice President - Finance | ||
| Jacob Amidror, Director | ||
| Nitzan Lotringer, Cultivation Director | ||
| Yogev Sarid, Chief Executive Officer, Director | ||
| Ofir Sarid, Vice President | ||
| Shira SittonDvorachek, HR Director | ||
| Shay Sarid, Chief Technology Officer, Director | ||
| Itamar Elitzur, Independent Director | ||
| Shira Dvorachek, Director of Human Resources |
Seach Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Seach Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0488 | |||
| Return On Asset | 0.0416 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.07 % | |||
| Shares Outstanding | 34.02 M | |||
| Shares Owned By Insiders | 64.06 % | |||
| Shares Owned By Institutions | 5.48 % | |||
| Price To Sales | 1.40 X | |||
| Revenue | 124.68 M | |||
| Gross Profit | 23 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Seach Stock
Seach Medical financial ratios help investors to determine whether Seach Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seach with respect to the benefits of owning Seach Medical security.